Vinge has advised the sellers in connection with the sale of all shares in Bygglet Holding AB to Cordel Norden AS, one of Valedo Partner’s portfolio companies.
Vinge has advised Radonova Laboratories AB, which is part of the Lagercrantz Group, in conjunction with the acquisition of the radon measuring instrument operations within Gammadata Instrument AB.
Vinge has advised Lagercrantz Group in connection with the acquisition of the German company Schmitztechnik GmbH, which is a market leader in several OEM segments with customer specific silicon, rubber, PUR and industrial plastic products with Germany as its largest market.
Advokatfirman Vinge has advised Pulsen Production AB in conjunction with the acquisition of the Borås based IT company Make IT i Borås AB from XXIT i Borås AB.
Vinge has advised CGNEE Sweden Holding AB in connection with the acquisition of North Pole Vindkraft Holding AB from Green Investment Group Limited and GE Capital Global Energy Investment B.V.
Vinge is advising Dole Food Company, Inc., in connection with the sale of all of the shares in Saba Fresh Cuts AB and Saba Fresh Cuts Oy to BAMA International AS.
The board of directors of Xspray Pharma AB (publ) has resolved on a directed new issue of shares, whereby Xspray Pharma will raise proceeds of approximately SEK 92 million, before issue costs.
Vinge advises Biotage AB (publ) (“Biotage”), listed on Nasdaq Stockholm, in connection with its acquisition of PhyNexus, Inc. (“PhyNexus”), financed through a combination of newly issued shares and existing cash at hand.
Vinge has assisted Stendörren Fastigheter AB (publ) (“Stendörren”) in connection with EQT Real Estate II’s, through Chicago Holding AB (“Chicago Holding”), cash offer to the shareholders in Stendörren.
The board of directors of Vicore Pharma has resolved, subject to the approval by an extraordinary general meeting, on a directed new issue of shares, whereby Vicore Pharma will raise proceeds of approximately SEK 160 million before issue costs.